195 related articles for article (PubMed ID: 17024549)
1. Neuroleptic-induced dysphagia: case report and literature review.
Dziewas R; Warnecke T; Schnabel M; Ritter M; Nabavi DG; Schilling M; Ringelstein EB; Reker T
Dysphagia; 2007 Jan; 22(1):63-7. PubMed ID: 17024549
[TBL] [Abstract][Full Text] [Related]
2. Extrapyramidal syndrome presenting as dysphagia: a case report.
Gonzalez F
Am J Hosp Palliat Care; 2008; 25(5):398-400. PubMed ID: 19047493
[TBL] [Abstract][Full Text] [Related]
3. Neuroleptic-induced dysphagia.
Sokoloff LG; Pavlakovic R
Dysphagia; 1997; 12(4):177-9. PubMed ID: 9294935
[TBL] [Abstract][Full Text] [Related]
4. The relationship between negative symptoms of schizophrenia and extrapyramidal side effects with haloperidol and olanzapine.
Allan ER; Sison CE; Alpert M; Connolly B; Crichton J
Psychopharmacol Bull; 1998; 34(1):71-4. PubMed ID: 9564201
[TBL] [Abstract][Full Text] [Related]
5. Neuroleptic-associated dysphagia confirmed by esophageal manometry.
Moss HB; Green A
Am J Psychiatry; 1982 Apr; 139(4):515-6. PubMed ID: 6121491
[No Abstract] [Full Text] [Related]
6. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
Tada M; Shirakawa K; Matsuoka N; Mutoh S
Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
[TBL] [Abstract][Full Text] [Related]
7. [Dysphagia or dysphagias during neuroleptic medication?].
Chaumartin N; Monville M; Lachaux B
Encephale; 2012 Sep; 38(4):351-5. PubMed ID: 22980477
[TBL] [Abstract][Full Text] [Related]
8. Sudden dysphagia with uvular enlargement following the initiation of risperidone which responded to benztropine: was this an extrapyramidal side effect?
Nair S; Saeed O; Shahab H; Sedky K; Garver D; Lippmann S
Gen Hosp Psychiatry; 2001; 23(4):231-2. PubMed ID: 11569473
[No Abstract] [Full Text] [Related]
9. Systematic review of case reports of oropharyngeal dysphagia following the use of antipsychotics.
Miarons M; Rofes L
Gastroenterol Hepatol; 2019 Apr; 42(4):209-227. PubMed ID: 30470564
[TBL] [Abstract][Full Text] [Related]
10. Biperiden and haloperidol plasma levels and extrapyramidal side effects in schizophrenic patients.
Meszaros K; Lenzinger E; Hornik K; Schönbeck G; Hatzinger R; Langer G; Sieghart W; Aschauer HN
Neuropsychobiology; 1997; 36(2):69-72. PubMed ID: 9267855
[TBL] [Abstract][Full Text] [Related]
11. High dosage of aripiprazole-induced dysphagia.
Lin TW; Lee BS; Liao YC; Chiu NY; Hsu WY
Int J Eat Disord; 2012 Mar; 45(2):305-6. PubMed ID: 21541978
[TBL] [Abstract][Full Text] [Related]
12. An analysis of safety and tolerability data from controlled, comparative studies of quetiapine in patients with schizophrenia, focusing on extrapyramidal symptoms.
Timdahl K; Carlsson A; Stening G
Hum Psychopharmacol; 2007 Jul; 22(5):315-25. PubMed ID: 17542047
[TBL] [Abstract][Full Text] [Related]
13. Neurologic side effects in neuroleptic-naïve patients treated with haloperidol or risperidone.
Windhaber J; Urbanits S; Grisold W
Neurology; 2000 Apr; 54(7):1543-4. PubMed ID: 10751282
[No Abstract] [Full Text] [Related]
14. Neuroleptic malignant syndrome and neuroleptic-induced catatonia: differential diagnosis and treatment.
Stoudemire A; Luther JS
Int J Psychiatry Med; 1984; 14(1):57-63. PubMed ID: 6145675
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced dysphagia.
Bulling M
Aust N Z J Med; 1999 Oct; 29(5):748. PubMed ID: 10630662
[No Abstract] [Full Text] [Related]
16. Antipsychotic medication and oropharyngeal dysphagia: systematic review.
Miarons Font M; Rofes Salsench L
Eur J Gastroenterol Hepatol; 2017 Dec; 29(12):1332-1339. PubMed ID: 29023321
[TBL] [Abstract][Full Text] [Related]
17. Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatment.
Wright P; Lindborg SR; Birkett M; Meehan K; Jones B; Alaka K; Ferchland-Howe I; Pickard A; Taylor CC; Roth J; Battaglia J; Bitter I; Chouinard G; Morris PL; Breier A
Can J Psychiatry; 2003 Dec; 48(11):716-21. PubMed ID: 14733451
[TBL] [Abstract][Full Text] [Related]
18. [The use of nifedipine as a corrector of extrapyramidal side-effects of classical neuroleptics].
Popov MIu
Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(6):28-33. PubMed ID: 18577931
[TBL] [Abstract][Full Text] [Related]
19. Behavioural effects of chronic haloperidol and risperidone treatment in rats.
Karl T; Duffy L; O'brien E; Matsumoto I; Dedova I
Behav Brain Res; 2006 Aug; 171(2):286-94. PubMed ID: 16697060
[TBL] [Abstract][Full Text] [Related]
20. [Testing basic visual functions in the evaluation of extrapyramidal side effects of antipsychotic agents].
Kéri S; Antal A; Szekeres G; Szendi I; Kovács Z; Janka Z; Benedek G
Orv Hetil; 1998 Feb; 139(5):235-8. PubMed ID: 9489377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
